Clinical Trial Update: Neoadjuvant Therapy of SBRT Sequencial with Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) [Phase 3]

View source ↗

Summary

Phase 3 neoadjuvant trial evaluating SBRT sequential therapy with toripalimab and chemotherapy in resectable Stage II-III non-small cell lung cancer. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (unspecified regimen)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Stage II-III Non-small Cell Lung Cancer | Phase 3 | Status: RECRUITING